Form 4: Sokolow Reports Changes in SKYX Platforms Corp. Beneficial Ownership

Sentiment:

SEC Form 4


Leonard J. Sokolow, Co-Chief Executive Officer of SKYX Platforms Corp., reports changes in beneficial ownership, including the disposition of common stock and acquisition of Series A-1 Preferred Stock.

Summary

  • On October 7, 2024, Leonard J. Sokolow, Co-Chief Executive Officer of SKYX Platforms Corp., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
  • The report indicates the disposition of 741,220 shares of common stock.
  • Sokolow also acquired 10,000 shares of Series A-1 Preferred Stock on October 4, 2024.
  • The Series A-1 Preferred Stock has an original issue price of $25.00 per share and is convertible into common stock at an initial conversion price of $2.00 per share, subject to adjustments.
  • Sokolow continues to hold various stock options and warrants to purchase SKYX common stock at different exercise prices and expiration dates.
  • He also holds a Subordinated Convertible Promissory Note convertible into common stock at $3.00 per share.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing. The disposition of shares could be seen as slightly negative, but the acquisition of preferred stock is neutral. Overall, the sentiment is neutral.

Negatives

  • The disposition of 741,220 shares of common stock by the Co-CEO could be interpreted negatively by the market.

Risks

  • The conversion of preferred stock and exercise of options and warrants could dilute existing shareholders' equity.
  • The market's reaction to the Co-CEO's stock disposition is uncertain.

Industry Context

Form 4 filings are a standard part of regulatory compliance for company insiders and provide transparency into their transactions in the company's securities. The market often scrutinizes these filings for signals about management's confidence in the company's prospects.

Stakeholder Impact

  • Shareholders may react to the reported changes in beneficial ownership.
  • The potential dilution from the conversion of preferred stock and exercise of options could impact shareholder value.

Key Dates

DateDescription
11/15/2015Date of stock option grant with an exercise price of $0.60 and an expiration date of 11/15/2025
06/30/2017Date of stock option grant with an exercise price of $3.00 and an expiration date of 04/19/2027
12/31/2017Date of stock option grant with an exercise price of $4.00 and an expiration date of 04/19/2027
01/01/2020Date of stock option grant with an exercise price of $12.00 and an expiration date of 01/01/2025
12/31/2020Date of stock option grant with an exercise price of $12.00 and an expiration date of 12/31/2025
12/31/2021Date of stock option grant with an exercise price of $12.00 and an expiration date of 12/31/2026
03/31/2022Date of stock option grant with an exercise price of $12.34 and an expiration date of 03/11/2027
04/30/2023Date of stock option grant with an exercise price of $3.28 and an expiration date of 04/05/2028
09/12/2023Date of stock option grant with an exercise price of $1.58 and an expiration date of 09/12/2028; 120,000 shares vested on this date
03/12/2024Start date for semi-annual vesting installments of 50,000 shares each for 300,000 options
10/04/2024Date of transaction for the acquisition of 10,000 shares of Series A-1 Preferred Stock.
10/07/2024Date of Form 4 filing.
10/26/2024Warrant expiration date for 1,088 shares of common stock at $9.80
11/29/2024Warrant expiration date for 3,375 shares of common stock at $9.80
12/22/2024Warrant expiration date for 19,827 shares of common stock at $9.80
01/01/2025Expiration date of stock options to purchase 100,000 shares of common stock at $12.00
03/12/2025Start date for semi-annual vesting installments of 50,000 restricted stock units each for 200,000 units
05/16/2025Maturity date of Subordinated Convertible Promissory Note convertible into common stock at $3.00 per share.
12/31/2025Expiration date of stock options to purchase 100,000 shares of common stock at $12.00
12/31/2026Expiration date of stock options to purchase 100,000 shares of common stock at $12.00
03/11/2027Expiration date of stock options to purchase 17,500 shares of common stock at $12.34
03/12/2027Vesting date for 30,000 restricted stock units
04/19/2027Expiration date of stock options to purchase 150,000 shares of common stock at $3.00 and $4.00
10/04/2027Earliest date the issuer may redeem the Preferred Stock for cash.
04/05/2028Expiration date of stock options to purchase 17,500 shares of common stock at $3.28
09/12/2028Expiration date of stock options to purchase 450,000 shares of common stock at $1.58

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.